Literature DB >> 25705024

Treatment of mastitis in cattle.

Erin Royster1, Sarah Wagner2.   

Abstract

The understanding of mastitis, its cause, and the rationale for treatment or nontreatment of mastitis under various circumstances continues to evolve. This article presents research-based evidence about the use or nonuse of drugs to treat mastitis. Nondrug factors involved in decision making about mastitis, including cow characteristics and the epidemiology of mastitis, are also briefly discussed. This article provides information that helps in the making of knowledgeable, evidence-based decisions about therapy for mastitis. Focus is primarily on the use of antimicrobial drugs.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobial; Cow; Dairy; Dry; Evidence; Lactating; Mastitis; Therapy

Mesh:

Substances:

Year:  2015        PMID: 25705024     DOI: 10.1016/j.cvfa.2014.11.010

Source DB:  PubMed          Journal:  Vet Clin North Am Food Anim Pract        ISSN: 0749-0720            Impact factor:   3.357


  13 in total

1.  Salvia miltiorrhiza polysaccharides ameliorates Staphylococcus aureus-induced mastitis in rats by inhibiting activation of the NF-κB and MAPK signaling pathways.

Authors:  Di Zhang; Guozhong Jin; Wei Liu; Mengmeng Dou; Xiao Wang; Wanyu Shi; Yongzhan Bao
Journal:  BMC Vet Res       Date:  2022-05-27       Impact factor: 2.792

Review 2.  Precision Technologies to Address Dairy Cattle Welfare: Focus on Lameness, Mastitis and Body Condition.

Authors:  Severiano R Silva; José P Araujo; Cristina Guedes; Flávio Silva; Mariana Almeida; Joaquim L Cerqueira
Journal:  Animals (Basel)       Date:  2021-07-30       Impact factor: 3.231

3.  A novel Streptococcus species causing clinical mastitis in a pregnant donkey.

Authors:  Giorgia Podico; Sarah M Gray; Leyi Wang; Igor F Canisso
Journal:  J Vet Diagn Invest       Date:  2021-07-10       Impact factor: 1.569

4.  Evaluation of an On-Farm Culture System (Accumast) for Fast Identification of Milk Pathogens Associated with Clinical Mastitis in Dairy Cows.

Authors:  Erika Korzune Ganda; Rafael Sisconeto Bisinotto; Dean Harrison Decter; Rodrigo Carvalho Bicalho
Journal:  PLoS One       Date:  2016-05-13       Impact factor: 3.240

5.  Staphylococcus aureus and Lipopolysaccharide Modulate Gene Expressions of Drug Transporters in Mouse Mammary Epithelial Cells Correlation to Inflammatory Biomarkers.

Authors:  Yagmur Yagdiran; Jonas Tallkvist; Karin Artursson; Agneta Oskarsson
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

6.  Efficacy Prediction of Four Pharmaceutical Formulations for Intramammary Administration Containing Aloe vera (L.) Burm. f. Combined With Ceftiofur or Cloxacillin in Lactating Cows as an Alternative Therapy to Treat Mastitis Caused by Staphylococcus aureus.

Authors:  Natalia Forno-Bell; Marcos A Munoz; Oscar Chacón; Paulina Pachá; Daniela Iragüen; Javiera Cornejo; Betty San Martín
Journal:  Front Vet Sci       Date:  2021-03-22

7.  Antibacterial Effect of Copper on Microorganisms Isolated from Bovine Mastitis.

Authors:  Angelica Reyes-Jara; Ninoska Cordero; Juan Aguirre; Miriam Troncoso; Guillermo Figueroa
Journal:  Front Microbiol       Date:  2016-04-28       Impact factor: 5.640

8.  Efficacy of recombinant bovine epidermal growth factor in the treatment of experimental subclinical Staphylococcus aureus mastitis in a ewe model.

Authors:  Kamal Gabadage; Manuel Chirino-Trejo; John Campbell; Christopher Luby
Journal:  Vet Rec Open       Date:  2017-05-01

9.  Successful treatment of recurrent subclinical mastitis in cows caused by enrofloxacin resistant bacteria by means of the sequential intramammary infusion of enrofloxacin HCl-2H2O and ceftiofur HCl: a clinical trial.

Authors:  Edgar Alfonseca-Silva; Juan Carlos Cruz-Villa; Lilia Gutiérrez; Hector Sumano
Journal:  J Vet Sci       Date:  2021-09-09       Impact factor: 1.672

10.  A Bioengineered Nisin Derivative To Control Streptococcus uberis Biofilms.

Authors:  Mariana Pérez-Ibarreche; Des Field; R Paul Ross; Colin Hill
Journal:  Appl Environ Microbiol       Date:  2021-07-27       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.